Weight-loss drugs and early pregnancy: what a study of 750,000 births found
Danish researchers saw no rise in complications when the drugs were taken for weight loss. The picture was different for women with diabetes.
By GlobalTidingsPublished 2 min read
Drugs such as semaglutide, sold as Ozempic and Wegovy, are not approved for use in pregnancy. Because so many people now take them, some women conceive while on treatment. A large Danish study gives the clearest picture so far of what that means.
The research was published in March in the journal Human Reproduction Open and has drawn renewed attention this month. It used national health registers covering 756,636 pregnancies among 480,231 women who gave birth between October 2009 and December 2023. In 529 of those pregnancies, the mother had collected a prescription for semaglutide or liraglutide within eight weeks either side of her last period.
What the researchers found
- Among women taking the drugs for weight loss, there was no link to premature birth or to the other complications studied.
- Among women taking them for diabetes that existed before pregnancy, premature birth was more common than in matched women who had not taken the drugs.
The authors said the results fit the idea that diabetes itself, rather than the medicine, may account for the higher risk. The study was led by Professor Henriette Svarre Nielsen of Copenhagen University Hospital Hvidovre.
What it does not show
This was an observational study. It can show that two things occur together but cannot prove that one causes the other. The number of exposed pregnancies was small, and the study looked at exposure around conception, not at use throughout pregnancy.
The researchers said future studies need to separate women by the reason the drug was prescribed, because the risks differ between the two groups.
This article is general information, not medical advice. Anyone who is pregnant or planning a pregnancy while taking these medicines should speak to their doctor before changing treatment.
Sources
- Human Reproduction Open (Oxford University Press)
- Scimex: Oxford University Press news release
- News-Medical
Written by GlobalTidings from the reporting and documents listed above. See our editorial standards.